Загрузка...
E2F1 inhibits circulating cholesterol clearance by regulating Pcsk9 expression in the liver
Cholesterol accumulation in the liver is an early event in nonalcoholic fatty liver disease (NAFLD). Here, we demonstrate that E2F1 plays a crucial role in maintaining cellular cholesterol homeostasis by regulating cholesterol uptake via proprotein convertase subtilisin/kexin 9 (PCSK9), an enzyme th...
Сохранить в:
| Опубликовано в: : | JCI Insight |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436545/ https://ncbi.nlm.nih.gov/pubmed/28515357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89729 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|